APO Research
Talk to an analyst

APO RESEARCH · REPORT

Group A and C Meningococcal Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Group A and C Meningococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032

27 December 2025101 pages

Choose your research edition.

Industry ResearchGroup A and C Meningococcal Polysaccharide Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Group A and C Meningococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Group A and C Meningococcal Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Group A and C Meningococcal Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Group A and C Meningococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Group A and C Meningococcal Polysaccharide Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Group A and C Meningococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Group A and C Meningococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Group A and C Meningococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Group A and C Meningococcal Polysaccharide Vaccine include Pfizer, Sanofi Pasteur, AIM Bio, Chengda Biotechnology, GlaxoSmithKline, Cansino Biologics, Sinovac, Lanzhou Institute of Biological Products and Royal (Wuxi) Bio-Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Group A and C Meningococcal Polysaccharide Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Group A and C Meningococcal Polysaccharide Vaccine market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Group A and C Meningococcal Polysaccharide Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Group A and C Meningococcal Polysaccharide Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Group A and C Meningococcal Polysaccharide Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Group A and C Meningococcal Polysaccharide Vaccine Market by Company

Pfizer

Sanofi Pasteur

AIM Bio

Chengda Biotechnology

GlaxoSmithKline

Cansino Biologics

Sinovac

Lanzhou Institute of Biological Products

Royal (Wuxi) Bio-Pharmaceutical

Merck & Co.

Toyouvax

Walvax

Zhifei Biological

Group A and C Meningococcal Polysaccharide Vaccine Segment by Type

Polysaccharide-protein Conjugate Vaccine

Polysaccharide Vaccine

Group A and C Meningococcal Polysaccharide Vaccine Segment by Application

Hospital

Centers for Disease Control and Prevention

Others

Group A and C Meningococcal Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Group A and C Meningococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Group A and C Meningococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Group A and C Meningococcal Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Group A and C Meningococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Group A and C Meningococcal Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Polysaccharide-protein Conjugate Vaccine Table 2. Major Company of Polysaccharide Vaccine Table 3. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 5. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Group A and C Meningococcal Polysaccharide Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (Units) Table 10. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Group A and C Meningococcal Polysaccharide Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 15. North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 17. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 19. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 21. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 23. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Group A and C Meningococcal Polysaccharide Vaccine Industry Trends Table 25. Group A and C Meningococcal Polysaccharide Vaccine Industry Drivers Table 26. Group A and C Meningococcal Polysaccharide Vaccine Industry Opportunities and Challenges Table 27. Group A and C Meningococcal Polysaccharide Vaccine Industry Restraints Table 28. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Company (2021-2026) & (Units) Table 31. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Share by Company (2021-2026) Table 32. Global Group A and C Meningococcal Polysaccharide Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Group A and C Meningococcal Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Group A and C Meningococcal Polysaccharide Vaccine Major Company Production Sites and Headquarters Table 35. Global Group A and C Meningococcal Polysaccharide Vaccine Company, Product Type & Application Table 36. Global Group A and C Meningococcal Polysaccharide Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Group A and C Meningococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (Units) Table 41. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (Units) Table 46. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 52. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Group A and C Meningococcal Polysaccharide Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (Units) Table 57. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Group A and C Meningococcal Polysaccharide Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 62. North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 64. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 66. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 68. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 70. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 75. Pfizer Recent Development Table 76. Sanofi Pasteur Company Information Table 77. Sanofi Pasteur Business Overview Table 78. Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 80. Sanofi Pasteur Recent Development Table 81. AIM Bio Company Information Table 82. AIM Bio Business Overview Table 83. AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 85. AIM Bio Recent Development Table 86. Chengda Biotechnology Company Information Table 87. Chengda Biotechnology Business Overview Table 88. Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 90. Chengda Biotechnology Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. Cansino Biologics Company Information Table 97. Cansino Biologics Business Overview Table 98. Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 100. Cansino Biologics Recent Development Table 101. Sinovac Company Information Table 102. Sinovac Business Overview Table 103. Sinovac Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 105. Sinovac Recent Development Table 106. Lanzhou Institute of Biological Products Company Information Table 107. Lanzhou Institute of Biological Products Business Overview Table 108. Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 110. Lanzhou Institute of Biological Products Recent Development Table 111. Royal (Wuxi) Bio-Pharmaceutical Company Information Table 112. Royal (Wuxi) Bio-Pharmaceutical Business Overview Table 113. Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 115. Royal (Wuxi) Bio-Pharmaceutical Recent Development Table 116. Merck & Co. Company Information Table 117. Merck & Co. Business Overview Table 118. Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 120. Merck & Co. Recent Development Table 121. Toyouvax Company Information Table 122. Toyouvax Business Overview Table 123. Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 125. Toyouvax Recent Development Table 126. Walvax Company Information Table 127. Walvax Business Overview Table 128. Walvax Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Walvax Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 130. Walvax Recent Development Table 131. Zhifei Biological Company Information Table 132. Zhifei Biological Business Overview Table 133. Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio Table 135. Zhifei Biological Recent Development Table 136. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 137. North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 138. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 139. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 140. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Group A and C Meningococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 144. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Group A and C Meningococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 146. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 147. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 148. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 149. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 150. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 154. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 158. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 160. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 164. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 166. Latin America Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 167. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 168. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 169. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 170. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Group A and C Meningococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 174. Latin America Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Group A and C Meningococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 178. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 180. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 184. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Group A and C Meningococcal Polysaccharide Vaccine Distributors List Table 189. Group A and C Meningococcal Polysaccharide Vaccine Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Group A and C Meningococcal Polysaccharide Vaccine Image Figure 2. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (2021-2032) & (Units) Figure 5. Polysaccharide-protein Conjugate Vaccine Image Figure 6. Global Polysaccharide-protein Conjugate Vaccine Sales YoY Growth (2021-2032) & (Units) Figure 7. Polysaccharide Vaccine Image Figure 8. Global Polysaccharide Vaccine Sales YoY Growth (2021-2032) & (Units) Figure 9. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Group A and C Meningococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (Units) Figure 25. Centers for Disease Control and Prevention Image Figure 26. Global Centers for Disease Control and Prevention Sales YoY Growth (2021-2032) & (Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 29. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 42. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Group A and C Meningococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Latin America Group A and C Meningococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Group A and C Meningococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Group A and C Meningococcal Polysaccharide Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Group A and C Meningococcal Polysaccharide Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Polysaccharide-protein Conjugate Vaccine
  • Polysaccharide Vaccine
Applications
  • Hospital
  • Centers for Disease Control and Prevention
  • Others
Companies covered
  • Pfizer
  • Sanofi Pasteur
  • AIM Bio
  • Chengda Biotechnology
  • GlaxoSmithKline
  • Cansino Biologics
  • Sinovac
  • Lanzhou Institute of Biological Products
  • Royal (Wuxi) Bio-Pharmaceutical
  • Merck & Co.
  • Toyouvax
  • Walvax
  • Zhifei Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Group A and C Meningococcal Polysaccharide Vaccine Market by Type
  6. 1.3.1 Polysaccharide-protein Conjugate Vaccine
  7. 1.3.2 Polysaccharide Vaccine
  8. 1.4 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Type
  9. 1.4.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Group A and C Meningococcal Polysaccharide Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Group A and C Meningococcal Polysaccharide Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Group A and C Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Group A and C Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Group A and C Meningococcal Polysaccharide Vaccine Industry Trends
  2. 2.2 Group A and C Meningococcal Polysaccharide Vaccine Industry Drivers
  3. 2.3 Group A and C Meningococcal Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 Group A and C Meningococcal Polysaccharide Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Group A and C Meningococcal Polysaccharide Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Group A and C Meningococcal Polysaccharide Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Group A and C Meningococcal Polysaccharide Vaccine Price (2021-2026)
  4. 3.4 Global Group A and C Meningococcal Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Group A and C Meningococcal Polysaccharide Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Group A and C Meningococcal Polysaccharide Vaccine Company, Product Type & Application
  7. 3.7 Global Group A and C Meningococcal Polysaccharide Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Group A and C Meningococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Group A and C Meningococcal Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
4 Group A and C Meningococcal Polysaccharide Vaccine Regional Status and Outlook
  1. 4.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Group A and C Meningococcal Polysaccharide Vaccine Historic Market Size by Region
  3. 4.2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Group A and C Meningococcal Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Group A and C Meningococcal Polysaccharide Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Group A and C Meningococcal Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Group A and C Meningococcal Polysaccharide Vaccine by Application
  1. 5.1 Group A and C Meningococcal Polysaccharide Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Centers for Disease Control and Prevention
  4. 5.1.3 Others
  5. 5.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Application
  6. 5.2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Group A and C Meningococcal Polysaccharide Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Group A and C Meningococcal Polysaccharide Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Group A and C Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Group A and C Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Sanofi Pasteur
  8. 6.2.1 Sanofi Pasteur Company Information
  9. 6.2.2 Sanofi Pasteur Business Overview
  10. 6.2.3 Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  12. 6.2.5 Sanofi Pasteur Recent Developments
  13. 6.3 AIM Bio
  14. 6.3.1 AIM Bio Company Information
  15. 6.3.2 AIM Bio Business Overview
  16. 6.3.3 AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  18. 6.3.5 AIM Bio Recent Developments
  19. 6.4 Chengda Biotechnology
  20. 6.4.1 Chengda Biotechnology Company Information
  21. 6.4.2 Chengda Biotechnology Business Overview
  22. 6.4.3 Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  24. 6.4.5 Chengda Biotechnology Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Cansino Biologics
  32. 6.6.1 Cansino Biologics Company Information
  33. 6.6.2 Cansino Biologics Business Overview
  34. 6.6.3 Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  36. 6.6.5 Cansino Biologics Recent Developments
  37. 6.7 Sinovac
  38. 6.7.1 Sinovac Company Information
  39. 6.7.2 Sinovac Business Overview
  40. 6.7.3 Sinovac Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  42. 6.7.5 Sinovac Recent Developments
  43. 6.8 Lanzhou Institute of Biological Products
  44. 6.8.1 Lanzhou Institute of Biological Products Company Information
  45. 6.8.2 Lanzhou Institute of Biological Products Business Overview
  46. 6.8.3 Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  48. 6.8.5 Lanzhou Institute of Biological Products Recent Developments
  49. 6.9 Royal (Wuxi) Bio-Pharmaceutical
  50. 6.9.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
  51. 6.9.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
  52. 6.9.3 Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  54. 6.9.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
  55. 6.10 Merck & Co.
  56. 6.10.1 Merck & Co. Company Information
  57. 6.10.2 Merck & Co. Business Overview
  58. 6.10.3 Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  60. 6.10.5 Merck & Co. Recent Developments
  61. 6.11 Toyouvax
  62. 6.11.1 Toyouvax Company Information
  63. 6.11.2 Toyouvax Business Overview
  64. 6.11.3 Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  66. 6.11.5 Toyouvax Recent Developments
  67. 6.12 Walvax
  68. 6.12.1 Walvax Company Information
  69. 6.12.2 Walvax Business Overview
  70. 6.12.3 Walvax Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Walvax Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  72. 6.12.5 Walvax Recent Developments
  73. 6.13 Zhifei Biological
  74. 6.13.1 Zhifei Biological Company Information
  75. 6.13.2 Zhifei Biological Business Overview
  76. 6.13.3 Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product Portfolio
  78. 6.13.5 Zhifei Biological Recent Developments
7 North America by Country
  1. 7.1 North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country
  2. 7.1.1 North America Group A and C Meningococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country
  6. 7.2.1 North America Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Country
  2. 8.1.1 Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country
  6. 8.2.1 Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country
  2. 10.1.1 South America Group A and C Meningococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country
  6. 10.2.1 South America Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Group A and C Meningococcal Polysaccharide Vaccine Value Chain Analysis
  2. 12.1.1 Group A and C Meningococcal Polysaccharide Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Group A and C Meningococcal Polysaccharide Vaccine Production Mode & Process
  7. 12.2 Group A and C Meningococcal Polysaccharide Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Group A and C Meningococcal Polysaccharide Vaccine Distributors
  10. 12.2.3 Group A and C Meningococcal Polysaccharide Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst